GlobeNewswire Inc.··NaLifecore Biomedical Lands Third Commercial Site Transfer in Medical Aesthetics Push
Lifecore Biomedical announces third commercial CDMO site transfer since October 2025, targeting 12% revenue CAGR through 2029.
LFCRCDMOcontract manufacturing